TY - JOUR
T1 - Genetic Risk Scores for Complex Disease Traits in Youth
AU - Xie, Tian
AU - Wang, Bin
AU - Nolte, Ilja M
AU - van der Most, Peter J
AU - Oldehinkel, Albertine J
AU - Hartman, Catharina A
AU - Snieder, Harold
PY - 2020/8
Y1 - 2020/8
N2 - Background: For most disease-related traits the magnitude of the contribution of genetic factors in adolescents remains unclear. Methods: Twenty continuous traits related to anthropometry, cardiovascular and renal function, metabolism, and inflammation were selected from the ongoing prospective Tracking Adolescents' Individual Lives Survey cohort in the Netherlands with measurements of up to 5 waves from age 11 to 22 years (n=1354, 47.6% males) and all traits available at the third wave (mean age [SD]=16.22 [0.66]). For each trait, unweighted and weighted genetic risk scores (GRSs) were generated based on significantly associated single nucleotide polymorphisms identified from literature. The variance explained by the GRSs in adolescents were estimated by linear regression after adjustment for covariates. Results: Except for ALT (alanine transaminase), all GRSs were significantly associated with their traits. The trait variance explained by the GRSs was highest for lipoprotein[a] (39.59%) and varied between 0.09% (ALT) and 18.49% (LDL [low-density lipoprotein]) for the other traits. For most traits, the variances explained in adolescents were comparable with or slightly smaller than those in adults. Significant increases of trait levels (except ALT) and increased risks for overweight/obesity (odds ratio, 6.41 [95% CI, 2.95-15.56]) and hypertension (odds ratio, 2.86 [95% CI, 1.39-6.17]) were found in individuals in the top GRS decile compared with those at the bottom decile. Conclusions: Variances explained by adult-based GRSs for disease-related traits in adolescents, although still relatively modest, were comparable with or slightly smaller than in adults offering promise for improved risk prediction at early ages.
AB - Background: For most disease-related traits the magnitude of the contribution of genetic factors in adolescents remains unclear. Methods: Twenty continuous traits related to anthropometry, cardiovascular and renal function, metabolism, and inflammation were selected from the ongoing prospective Tracking Adolescents' Individual Lives Survey cohort in the Netherlands with measurements of up to 5 waves from age 11 to 22 years (n=1354, 47.6% males) and all traits available at the third wave (mean age [SD]=16.22 [0.66]). For each trait, unweighted and weighted genetic risk scores (GRSs) were generated based on significantly associated single nucleotide polymorphisms identified from literature. The variance explained by the GRSs in adolescents were estimated by linear regression after adjustment for covariates. Results: Except for ALT (alanine transaminase), all GRSs were significantly associated with their traits. The trait variance explained by the GRSs was highest for lipoprotein[a] (39.59%) and varied between 0.09% (ALT) and 18.49% (LDL [low-density lipoprotein]) for the other traits. For most traits, the variances explained in adolescents were comparable with or slightly smaller than those in adults. Significant increases of trait levels (except ALT) and increased risks for overweight/obesity (odds ratio, 6.41 [95% CI, 2.95-15.56]) and hypertension (odds ratio, 2.86 [95% CI, 1.39-6.17]) were found in individuals in the top GRS decile compared with those at the bottom decile. Conclusions: Variances explained by adult-based GRSs for disease-related traits in adolescents, although still relatively modest, were comparable with or slightly smaller than in adults offering promise for improved risk prediction at early ages.
KW - adolescent
KW - blood pressure
KW - body mass index
KW - genetic predisposition to disease
KW - genetic variation
KW - GENOME-WIDE ASSOCIATION
KW - BODY-MASS INDEX
KW - INDIVIDUAL-LIVES SURVEY
KW - BLOOD-PRESSURE
KW - GLYCEMIC TRAITS
KW - COHORT PROFILE
KW - PLASMA-LIPIDS
KW - HEART-RATE
KW - LOCI
KW - CHILDHOOD
U2 - 10.1161/CIRCGEN.119.002775
DO - 10.1161/CIRCGEN.119.002775
M3 - Article
C2 - 32527150
SN - 2574-8300
VL - 13
SP - 212
EP - 221
JO - Circulation. Genomic and precision medicine
JF - Circulation. Genomic and precision medicine
IS - 4
M1 - e002775
ER -